nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Prednisone—psoriatic arthritis	0.033	0.382	CbGbCtD
Moclobemide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0206	0.239	CbGbCtD
Moclobemide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0171	0.198	CbGbCtD
Moclobemide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0157	0.181	CbGbCtD
Moclobemide—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00437	0.00479	CcSEcCtD
Moclobemide—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00437	0.00479	CcSEcCtD
Moclobemide—Migraine—Dexamethasone—psoriatic arthritis	0.00431	0.00471	CcSEcCtD
Moclobemide—Migraine—Betamethasone—psoriatic arthritis	0.00431	0.00471	CcSEcCtD
Moclobemide—Abdominal distension—Triamcinolone—psoriatic arthritis	0.0042	0.00459	CcSEcCtD
Moclobemide—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00419	0.00458	CcSEcCtD
Moclobemide—Irritability—Dexamethasone—psoriatic arthritis	0.00418	0.00457	CcSEcCtD
Moclobemide—Irritability—Betamethasone—psoriatic arthritis	0.00418	0.00457	CcSEcCtD
Moclobemide—Dry skin—Dexamethasone—psoriatic arthritis	0.00401	0.00439	CcSEcCtD
Moclobemide—Dry skin—Betamethasone—psoriatic arthritis	0.00401	0.00439	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—psoriatic arthritis	0.00397	0.00434	CcSEcCtD
Moclobemide—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00393	0.0043	CcSEcCtD
Moclobemide—Osteoarthritis—Prednisone—psoriatic arthritis	0.00381	0.00417	CcSEcCtD
Moclobemide—Bradycardia—Prednisolone—psoriatic arthritis	0.00369	0.00404	CcSEcCtD
Moclobemide—Irritability—Prednisone—psoriatic arthritis	0.00364	0.00398	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—psoriatic arthritis	0.00363	0.00397	CcSEcCtD
Moclobemide—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00361	0.00395	CcSEcCtD
Moclobemide—Sweating—Methylprednisolone—psoriatic arthritis	0.00355	0.00389	CcSEcCtD
Moclobemide—Visual impairment—Prednisolone—psoriatic arthritis	0.0035	0.00383	CcSEcCtD
Moclobemide—Dry skin—Prednisone—psoriatic arthritis	0.00349	0.00382	CcSEcCtD
Moclobemide—Bradycardia—Triamcinolone—psoriatic arthritis	0.0034	0.00372	CcSEcCtD
Moclobemide—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00339	0.00371	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—psoriatic arthritis	0.00336	0.00368	CcSEcCtD
Moclobemide—Abdominal distension—Prednisone—psoriatic arthritis	0.00332	0.00363	CcSEcCtD
Moclobemide—Hallucination—Methylprednisolone—psoriatic arthritis	0.00331	0.00362	CcSEcCtD
Moclobemide—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00328	0.00359	CcSEcCtD
Moclobemide—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00328	0.00359	CcSEcCtD
Moclobemide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00321	0.00351	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00318	0.00349	CcSEcCtD
Moclobemide—Bradycardia—Dexamethasone—psoriatic arthritis	0.00308	0.00337	CcSEcCtD
Moclobemide—Bradycardia—Betamethasone—psoriatic arthritis	0.00308	0.00337	CcSEcCtD
Moclobemide—Irritability—Methotrexate—psoriatic arthritis	0.00304	0.00333	CcSEcCtD
Moclobemide—Hallucination—Betamethasone—psoriatic arthritis	0.00301	0.0033	CcSEcCtD
Moclobemide—Hallucination—Dexamethasone—psoriatic arthritis	0.00301	0.0033	CcSEcCtD
Moclobemide—Vision blurred—Prednisolone—psoriatic arthritis	0.00298	0.00326	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00293	0.00321	CcSEcCtD
Moclobemide—Visual impairment—Dexamethasone—psoriatic arthritis	0.00292	0.00319	CcSEcCtD
Moclobemide—Visual impairment—Betamethasone—psoriatic arthritis	0.00292	0.00319	CcSEcCtD
Moclobemide—Malaise—Prednisolone—psoriatic arthritis	0.00285	0.00312	CcSEcCtD
Moclobemide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00284	0.00311	CcSEcCtD
Moclobemide—Syncope—Prednisolone—psoriatic arthritis	0.00283	0.0031	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00278	0.00304	CcSEcCtD
Moclobemide—Hypertension—Prednisolone—psoriatic arthritis	0.00273	0.00298	CcSEcCtD
Moclobemide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00269	0.00295	CcSEcCtD
Moclobemide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00269	0.00294	CcSEcCtD
Moclobemide—Bradycardia—Prednisone—psoriatic arthritis	0.00268	0.00294	CcSEcCtD
Moclobemide—Discomfort—Prednisolone—psoriatic arthritis	0.00266	0.00291	CcSEcCtD
Moclobemide—Hallucination—Prednisone—psoriatic arthritis	0.00262	0.00287	CcSEcCtD
Moclobemide—Malaise—Triamcinolone—psoriatic arthritis	0.00262	0.00287	CcSEcCtD
Moclobemide—Malaise—Methylprednisolone—psoriatic arthritis	0.00261	0.00286	CcSEcCtD
Moclobemide—Syncope—Triamcinolone—psoriatic arthritis	0.0026	0.00285	CcSEcCtD
Moclobemide—Syncope—Methylprednisolone—psoriatic arthritis	0.0026	0.00284	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—psoriatic arthritis	0.00257	0.00282	CcSEcCtD
Moclobemide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00255	0.00279	CcSEcCtD
Moclobemide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00255	0.00279	CcSEcCtD
Moclobemide—Shock—Prednisolone—psoriatic arthritis	0.00254	0.00278	CcSEcCtD
Moclobemide—Tachycardia—Prednisolone—psoriatic arthritis	0.00252	0.00275	CcSEcCtD
Moclobemide—Hypertension—Triamcinolone—psoriatic arthritis	0.00251	0.00274	CcSEcCtD
Moclobemide—Hypertension—Methylprednisolone—psoriatic arthritis	0.0025	0.00274	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00249	0.00273	CcSEcCtD
Moclobemide—Myalgia—Triamcinolone—psoriatic arthritis	0.00247	0.00271	CcSEcCtD
Moclobemide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00247	0.0027	CcSEcCtD
Moclobemide—Anxiety—Methylprednisolone—psoriatic arthritis	0.00246	0.00269	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—psoriatic arthritis	0.00245	0.00269	CcSEcCtD
Moclobemide—Flushing—Prednisone—psoriatic arthritis	0.00245	0.00268	CcSEcCtD
Moclobemide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00244	0.00268	CcSEcCtD
Moclobemide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00244	0.00268	CcSEcCtD
Moclobemide—Discomfort—Triamcinolone—psoriatic arthritis	0.00244	0.00267	CcSEcCtD
Moclobemide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00244	0.00267	CcSEcCtD
Moclobemide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00242	0.00265	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—psoriatic arthritis	0.00239	0.00262	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00239	0.00261	CcSEcCtD
Moclobemide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00238	0.00261	CcSEcCtD
Moclobemide—Malaise—Betamethasone—psoriatic arthritis	0.00238	0.0026	CcSEcCtD
Moclobemide—Malaise—Dexamethasone—psoriatic arthritis	0.00238	0.0026	CcSEcCtD
Moclobemide—Syncope—Betamethasone—psoriatic arthritis	0.00236	0.00259	CcSEcCtD
Moclobemide—Syncope—Dexamethasone—psoriatic arthritis	0.00236	0.00259	CcSEcCtD
Moclobemide—Sweating—Methotrexate—psoriatic arthritis	0.00235	0.00258	CcSEcCtD
Moclobemide—Shock—Triamcinolone—psoriatic arthritis	0.00233	0.00255	CcSEcCtD
Moclobemide—Insomnia—Prednisolone—psoriatic arthritis	0.00233	0.00255	CcSEcCtD
Moclobemide—Shock—Methylprednisolone—psoriatic arthritis	0.00233	0.00255	CcSEcCtD
Moclobemide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00232	0.00253	CcSEcCtD
Moclobemide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00232	0.00253	CcSEcCtD
Moclobemide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00231	0.00253	CcSEcCtD
Moclobemide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00231	0.00253	CcSEcCtD
Moclobemide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00231	0.00253	CcSEcCtD
Moclobemide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00229	0.00251	CcSEcCtD
Moclobemide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00229	0.0025	CcSEcCtD
Moclobemide—Hypertension—Betamethasone—psoriatic arthritis	0.00227	0.00249	CcSEcCtD
Moclobemide—Hypertension—Dexamethasone—psoriatic arthritis	0.00227	0.00249	CcSEcCtD
Moclobemide—Myalgia—Dexamethasone—psoriatic arthritis	0.00224	0.00246	CcSEcCtD
Moclobemide—Myalgia—Betamethasone—psoriatic arthritis	0.00224	0.00246	CcSEcCtD
Moclobemide—Anxiety—Dexamethasone—psoriatic arthritis	0.00224	0.00245	CcSEcCtD
Moclobemide—Anxiety—Betamethasone—psoriatic arthritis	0.00224	0.00245	CcSEcCtD
Moclobemide—Discomfort—Dexamethasone—psoriatic arthritis	0.00222	0.00243	CcSEcCtD
Moclobemide—Discomfort—Betamethasone—psoriatic arthritis	0.00222	0.00243	CcSEcCtD
Moclobemide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00221	0.00242	CcSEcCtD
Moclobemide—Vision blurred—Prednisone—psoriatic arthritis	0.00216	0.00237	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00216	0.00236	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00215	0.00236	CcSEcCtD
Moclobemide—Insomnia—Triamcinolone—psoriatic arthritis	0.00214	0.00235	CcSEcCtD
Moclobemide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00214	0.00234	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00213	0.00233	CcSEcCtD
Moclobemide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00213	0.00233	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00212	0.00232	CcSEcCtD
Moclobemide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00212	0.00232	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—psoriatic arthritis	0.00212	0.00232	CcSEcCtD
Moclobemide—Shock—Dexamethasone—psoriatic arthritis	0.00212	0.00232	CcSEcCtD
Moclobemide—Shock—Betamethasone—psoriatic arthritis	0.00212	0.00232	CcSEcCtD
Moclobemide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00211	0.00231	CcSEcCtD
Moclobemide—Agitation—Prednisone—psoriatic arthritis	0.00211	0.00231	CcSEcCtD
Moclobemide—Tachycardia—Dexamethasone—psoriatic arthritis	0.0021	0.0023	CcSEcCtD
Moclobemide—Tachycardia—Betamethasone—psoriatic arthritis	0.0021	0.0023	CcSEcCtD
Moclobemide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00209	0.00228	CcSEcCtD
Moclobemide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00208	0.00228	CcSEcCtD
Moclobemide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00208	0.00228	CcSEcCtD
Moclobemide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00208	0.00228	CcSEcCtD
Moclobemide—Malaise—Prednisone—psoriatic arthritis	0.00207	0.00226	CcSEcCtD
Moclobemide—Syncope—Prednisone—psoriatic arthritis	0.00206	0.00225	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—psoriatic arthritis	0.00205	0.00225	CcSEcCtD
Moclobemide—Urticaria—Prednisolone—psoriatic arthritis	0.00205	0.00224	CcSEcCtD
Moclobemide—Fatigue—Triamcinolone—psoriatic arthritis	0.00204	0.00224	CcSEcCtD
Moclobemide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00204	0.00223	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00202	0.00221	CcSEcCtD
Moclobemide—Hypotension—Dexamethasone—psoriatic arthritis	0.00201	0.0022	CcSEcCtD
Moclobemide—Hypotension—Betamethasone—psoriatic arthritis	0.00201	0.0022	CcSEcCtD
Moclobemide—Hypertension—Prednisone—psoriatic arthritis	0.00198	0.00217	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00196	0.00214	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00196	0.00214	CcSEcCtD
Moclobemide—Myalgia—Prednisone—psoriatic arthritis	0.00195	0.00214	CcSEcCtD
Moclobemide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00195	0.00214	CcSEcCtD
Moclobemide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00195	0.00213	CcSEcCtD
Moclobemide—Anxiety—Prednisone—psoriatic arthritis	0.00195	0.00213	CcSEcCtD
Moclobemide—Insomnia—Dexamethasone—psoriatic arthritis	0.00194	0.00213	CcSEcCtD
Moclobemide—Insomnia—Betamethasone—psoriatic arthritis	0.00194	0.00213	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00193	0.00212	CcSEcCtD
Moclobemide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00193	0.00211	CcSEcCtD
Moclobemide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00193	0.00211	CcSEcCtD
Moclobemide—Discomfort—Prednisone—psoriatic arthritis	0.00193	0.00211	CcSEcCtD
Moclobemide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00189	0.00207	CcSEcCtD
Moclobemide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00189	0.00207	CcSEcCtD
Moclobemide—Urticaria—Triamcinolone—psoriatic arthritis	0.00188	0.00206	CcSEcCtD
Moclobemide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00188	0.00206	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00188	0.00206	CcSEcCtD
Moclobemide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00187	0.00205	CcSEcCtD
Moclobemide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00187	0.00205	CcSEcCtD
Moclobemide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00187	0.00205	CcSEcCtD
Moclobemide—Fatigue—Dexamethasone—psoriatic arthritis	0.00185	0.00203	CcSEcCtD
Moclobemide—Fatigue—Betamethasone—psoriatic arthritis	0.00185	0.00203	CcSEcCtD
Moclobemide—Shock—Prednisone—psoriatic arthritis	0.00184	0.00202	CcSEcCtD
Moclobemide—Tachycardia—Prednisone—psoriatic arthritis	0.00183	0.002	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00181	0.00198	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—psoriatic arthritis	0.00181	0.00198	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00178	0.00195	CcSEcCtD
Moclobemide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00177	0.00194	CcSEcCtD
Moclobemide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00177	0.00194	CcSEcCtD
Moclobemide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00176	0.00192	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00176	0.00192	CcSEcCtD
Moclobemide—Malaise—Methotrexate—psoriatic arthritis	0.00173	0.00189	CcSEcCtD
Moclobemide—Urticaria—Betamethasone—psoriatic arthritis	0.00171	0.00187	CcSEcCtD
Moclobemide—Urticaria—Dexamethasone—psoriatic arthritis	0.00171	0.00187	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00171	0.00187	CcSEcCtD
Moclobemide—Dizziness—Prednisolone—psoriatic arthritis	0.0017	0.00187	CcSEcCtD
Moclobemide—Asthenia—Triamcinolone—psoriatic arthritis	0.0017	0.00186	CcSEcCtD
Moclobemide—Abdominal pain—Betamethasone—psoriatic arthritis	0.0017	0.00186	CcSEcCtD
Moclobemide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.0017	0.00186	CcSEcCtD
Moclobemide—Asthenia—Methylprednisolone—psoriatic arthritis	0.0017	0.00186	CcSEcCtD
Moclobemide—Insomnia—Prednisone—psoriatic arthritis	0.00169	0.00185	CcSEcCtD
Moclobemide—Paraesthesia—Prednisone—psoriatic arthritis	0.00168	0.00184	CcSEcCtD
Moclobemide—Pruritus—Triamcinolone—psoriatic arthritis	0.00168	0.00184	CcSEcCtD
Moclobemide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00167	0.00183	CcSEcCtD
Moclobemide—Dyspepsia—Prednisone—psoriatic arthritis	0.00165	0.0018	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—psoriatic arthritis	0.00163	0.00179	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—psoriatic arthritis	0.00163	0.00179	CcSEcCtD
Moclobemide—Decreased appetite—Prednisone—psoriatic arthritis	0.00163	0.00178	CcSEcCtD
Moclobemide—Rash—Prednisolone—psoriatic arthritis	0.00162	0.00178	CcSEcCtD
Moclobemide—Dermatitis—Prednisolone—psoriatic arthritis	0.00162	0.00178	CcSEcCtD
Moclobemide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00162	0.00177	CcSEcCtD
Moclobemide—Fatigue—Prednisone—psoriatic arthritis	0.00161	0.00177	CcSEcCtD
Moclobemide—Headache—Prednisolone—psoriatic arthritis	0.00161	0.00177	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—psoriatic arthritis	0.00161	0.00177	CcSEcCtD
Moclobemide—Constipation—Prednisone—psoriatic arthritis	0.0016	0.00175	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—psoriatic arthritis	0.00158	0.00173	CcSEcCtD
Moclobemide—Dizziness—Triamcinolone—psoriatic arthritis	0.00157	0.00172	CcSEcCtD
Moclobemide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00156	0.00171	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00154	0.00169	CcSEcCtD
Moclobemide—Asthenia—Dexamethasone—psoriatic arthritis	0.00154	0.00169	CcSEcCtD
Moclobemide—Asthenia—Betamethasone—psoriatic arthritis	0.00154	0.00169	CcSEcCtD
Moclobemide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00153	0.00168	CcSEcCtD
Moclobemide—Nausea—Prednisolone—psoriatic arthritis	0.00153	0.00168	CcSEcCtD
Moclobemide—Pruritus—Betamethasone—psoriatic arthritis	0.00152	0.00167	CcSEcCtD
Moclobemide—Pruritus—Dexamethasone—psoriatic arthritis	0.00152	0.00167	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00151	0.00166	CcSEcCtD
Moclobemide—Vomiting—Triamcinolone—psoriatic arthritis	0.00151	0.00165	CcSEcCtD
Moclobemide—Vomiting—Methylprednisolone—psoriatic arthritis	0.0015	0.00165	CcSEcCtD
Moclobemide—Rash—Triamcinolone—psoriatic arthritis	0.00149	0.00164	CcSEcCtD
Moclobemide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00149	0.00163	CcSEcCtD
Moclobemide—Rash—Methylprednisolone—psoriatic arthritis	0.00149	0.00163	CcSEcCtD
Moclobemide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00149	0.00163	CcSEcCtD
Moclobemide—Urticaria—Prednisone—psoriatic arthritis	0.00149	0.00163	CcSEcCtD
Moclobemide—Headache—Triamcinolone—psoriatic arthritis	0.00148	0.00163	CcSEcCtD
Moclobemide—Headache—Methylprednisolone—psoriatic arthritis	0.00148	0.00162	CcSEcCtD
Moclobemide—Abdominal pain—Prednisone—psoriatic arthritis	0.00148	0.00162	CcSEcCtD
Moclobemide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00147	0.00161	CcSEcCtD
Moclobemide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00147	0.00161	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—psoriatic arthritis	0.00146	0.0016	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00143	0.00156	CcSEcCtD
Moclobemide—Dizziness—Betamethasone—psoriatic arthritis	0.00142	0.00156	CcSEcCtD
Moclobemide—Dizziness—Dexamethasone—psoriatic arthritis	0.00142	0.00156	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—psoriatic arthritis	0.00142	0.00155	CcSEcCtD
Moclobemide—Nausea—Triamcinolone—psoriatic arthritis	0.00141	0.00154	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00141	0.00154	CcSEcCtD
Moclobemide—Nausea—Methylprednisolone—psoriatic arthritis	0.0014	0.00154	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—psoriatic arthritis	0.0014	0.00153	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—psoriatic arthritis	0.00139	0.00152	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00138	0.00151	CcSEcCtD
Moclobemide—Vomiting—Dexamethasone—psoriatic arthritis	0.00137	0.0015	CcSEcCtD
Moclobemide—Vomiting—Betamethasone—psoriatic arthritis	0.00137	0.0015	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00136	0.00149	CcSEcCtD
Moclobemide—Rash—Betamethasone—psoriatic arthritis	0.00136	0.00148	CcSEcCtD
Moclobemide—Rash—Dexamethasone—psoriatic arthritis	0.00136	0.00148	CcSEcCtD
Moclobemide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00135	0.00148	CcSEcCtD
Moclobemide—Dermatitis—Betamethasone—psoriatic arthritis	0.00135	0.00148	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—psoriatic arthritis	0.00135	0.00148	CcSEcCtD
Moclobemide—Headache—Dexamethasone—psoriatic arthritis	0.00135	0.00147	CcSEcCtD
Moclobemide—Headache—Betamethasone—psoriatic arthritis	0.00135	0.00147	CcSEcCtD
Moclobemide—Asthenia—Prednisone—psoriatic arthritis	0.00134	0.00147	CcSEcCtD
Moclobemide—Pruritus—Prednisone—psoriatic arthritis	0.00132	0.00145	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00129	0.00141	CcSEcCtD
Moclobemide—Diarrhoea—Prednisone—psoriatic arthritis	0.00128	0.0014	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00128	0.0014	CcSEcCtD
Moclobemide—Nausea—Betamethasone—psoriatic arthritis	0.00128	0.0014	CcSEcCtD
Moclobemide—Nausea—Dexamethasone—psoriatic arthritis	0.00128	0.0014	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—psoriatic arthritis	0.00124	0.00136	CcSEcCtD
Moclobemide—Dizziness—Prednisone—psoriatic arthritis	0.00124	0.00136	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00124	0.00135	CcSEcCtD
Moclobemide—Vomiting—Prednisone—psoriatic arthritis	0.00119	0.0013	CcSEcCtD
Moclobemide—Rash—Prednisone—psoriatic arthritis	0.00118	0.00129	CcSEcCtD
Moclobemide—Dermatitis—Prednisone—psoriatic arthritis	0.00118	0.00129	CcSEcCtD
Moclobemide—Headache—Prednisone—psoriatic arthritis	0.00117	0.00128	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—psoriatic arthritis	0.00112	0.00123	CcSEcCtD
Moclobemide—Nausea—Prednisone—psoriatic arthritis	0.00111	0.00122	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—psoriatic arthritis	0.00111	0.00121	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00107	0.00117	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—psoriatic arthritis	0.00103	0.00113	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—psoriatic arthritis	0.000995	0.00109	CcSEcCtD
Moclobemide—Rash—Methotrexate—psoriatic arthritis	0.000987	0.00108	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—psoriatic arthritis	0.000986	0.00108	CcSEcCtD
Moclobemide—Headache—Methotrexate—psoriatic arthritis	0.00098	0.00107	CcSEcCtD
Moclobemide—Nausea—Methotrexate—psoriatic arthritis	0.00093	0.00102	CcSEcCtD
